| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |
| mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
| mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |